Published in Emerg Infect Dis on December 01, 2010
DNA vaccine-generated duck polyclonal antibodies as a postexposure prophylactic to prevent hantavirus pulmonary syndrome (HPS). PLoS One (2012) 1.18
Host mTORC1 signaling regulates andes virus replication. J Virol (2012) 0.88
Hantavirus reservoirs: current status with an emphasis on data from Brazil. Viruses (2014) 0.87
Antiviral Biologic Produced in DNA Vaccine/Goose Platform Protects Hamsters Against Hantavirus Pulmonary Syndrome When Administered Post-exposure. PLoS Negl Trop Dis (2015) 0.78
Serological evidence of hantavirus infection in apparently healthy people from rural and slum communities in southern Chile. Viruses (2015) 0.78
Hantavirus pulmonary syndrome, Southern Chile, 1995-2012. Emerg Infect Dis (2015) 0.76
Andes Hantavirus-Infection of a 3D Human Lung Tissue Model Reveals a Late Peak in Progeny Virus Production Followed by Increased Levels of Proinflammatory Cytokines and VEGF-A. PLoS One (2016) 0.76
Massive plasmablast response elicited in the acute phase of Hantavirus Pulmonary Syndrome. Immunology (2017) 0.75
Estimating hantavirus risk in southern Argentina: a GIS-based approach combining human cases and host distribution. Viruses (2014) 0.75
Environmental Variables Associated with Hantavirus Reservoirs and Other Small Rodent Species in Two National Parks in the Paraná Delta, Argentina: Implications for Disease Prevention. Ecohealth (2016) 0.75
Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science (1993) 9.11
Genetic identification of a new hantavirus causing severe pulmonary syndrome in Argentina. Virology (1996) 2.98
Laguna Negra virus associated with HPS in western Paraguay and Bolivia. Virology (1997) 2.78
Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus. Virology (1998) 2.71
Genetic diversity and epidemiology of hantaviruses in Argentina. J Infect Dis (1998) 2.29
Hantavirus pulmonary syndrome in Panama: identification of novel hantaviruses and their likely reservoirs. Virology (2000) 2.03
Person-to-person transmission of Andes virus. Emerg Infect Dis (2005) 1.94
Genetic diversity, distribution, and serological features of hantavirus infection in five countries in South America. J Clin Microbiol (2000) 1.94
Genetic investigation of novel hantaviruses causing fatal HPS in Brazil. J Med Virol (1999) 1.92
Development and evaluation of a solid-phase enzyme immunoassay based on Andes hantavirus recombinant nucleoprotein. J Med Microbiol (2000) 1.70
Differential Th1 and Th2 cell responses in male and female BALB/c mice infected with coxsackievirus group B type 3. J Virol (1994) 1.64
Humoral immune responses in the hantavirus cardiopulmonary syndrome. J Infect Dis (2000) 1.56
An outbreak of hantavirus pulmonary syndrome, Chile, 1997. Emerg Infect Dis (1999) 1.54
[Retrospective detection of hantavirus clinical infections in Argentina]. Medicina (B Aires) (1996) 1.48
Hantavirus pulmonary syndrome. Lancet (1996) 1.40
Sex differences in susceptibility to viral infection of the central nervous system. J Neuroimmunol (1996) 1.31
Hantavirus pulmonary syndrome. Report of the first three cases in São Paulo, Brazil. Rev Inst Med Trop Sao Paulo (1998) 1.28
Hantavirus pulmonary syndrome in northwestern Argentina: circulation of Laguna Negra virus associated with Calomys callosus. Am J Trop Med Hyg (2004) 1.22
Serological evidence of human Hantavirus infection in Argentina, Bolivia and Uruguay. Medicina (B Aires) (1996) 1.10
Hantavirus pulmonary syndrome-related virus from Bolivia. Lancet (1996) 1.08
Sex-dependent differences in plasma cytokine responses to hantavirus infection. Clin Vaccine Immunol (2008) 1.07
Andes virus and first case report of Bermejo virus causing fatal pulmonary syndrome. Emerg Infect Dis (2002) 1.03
Pathogenic hantaviruses, northeastern Argentina and eastern Paraguay. Emerg Infect Dis (2007) 0.97
Sin Nombre virus-specific immunoglobulin M and G kinetics in hantavirus pulmonary syndrome and the role played by serologic responses in predicting disease outcome. J Infect Dis (2010) 0.95
[Hantavirus pulmonary syndrome in Buenos Aires Province]. Medicina (B Aires) (2001) 0.94
Distribution and abundance of sigmodontine rodents in relation to hantavirus in Neuquén, Argentina. J Vector Ecol (2005) 0.93
[New epidemiologic and molecular evidence of person to person transmission of hantavirus Andes Sout]. Medicina (B Aires) (2004) 0.90
Hantavirus pulmonary syndrome, southern Chile. Emerg Infect Dis (2003) 0.90
Yellow pigmy rice rat (Oligoryzomys flavescens) and hantavirus pulmonary syndrome in Uruguay. Emerg Infect Dis (2003) 0.90
Does the gender difference in interferon production seen in picornavirus-infected spleen cell cultures from ICR Swiss mice have any in vivo significance? J Interferon Res (1993) 0.89
[Hantavirus pulmonary syndrome in southern Argentina]. Medicina (B Aires) (2000) 0.88
[Pulmonary and cardiovascular syndrome due to hantavirus: clinical aspects of an emerging disease in southeastern Brazil]. Rev Soc Bras Med Trop (2009) 0.78
[Geographic expansion of hantavirus pulmonary syndrome in Argentina. The southernest case report]. Medicina (B Aires) (2009) 0.78
Hantavirus pulmonary syndrome in Uberaba, Minas Gerais, Brazil. Mem Inst Oswaldo Cruz (2002) 0.78
Hantavirus antibodies in rodents and human cases with pulmonary syndrome, Rio Negro, Argentina. Medicina (B Aires) (2008) 0.77
Person-to-person transmission of Andes virus. Emerg Infect Dis (2005) 1.94
Newly recognized hantaviruses associated with hantavirus pulmonary syndrome in northern Brazil: partial genetic characterization of viruses and serologic implication of likely reservoirs. Vector Borne Zoonotic Dis (2005) 1.42
Methamphetamine use parameters do not predict neuropsychological impairment in currently abstinent dependent adults. Drug Alcohol Depend (2009) 1.08
Cognitive functioning in younger and older HIV-1-infected adults. J Acquir Immune Defic Syndr (2003) 1.06
Older age and plasma viral load in HIV-1 infection. AIDS (2004) 1.04
[New epidemiologic and molecular evidence of person to person transmission of hantavirus Andes Sout]. Medicina (B Aires) (2004) 0.90
Genetic characterization of hantaviruses associated with sigmodontine rodents in an endemic area for hantavirus pulmonary syndrome in southern Brazil. Vector Borne Zoonotic Dis (2010) 0.90
Diversity Summit 2008: challenges in the recruitment and retention of ethnic minorities in neuropsychology. Clin Neuropsychol (2010) 0.85
Challenges in the neuropsychological assessment of ethnic minorities: summit proceedings. Clin Neuropsychol (2009) 0.83
Prevalence of infection with hantavirus in rodent populations of central Argentina. Mem Inst Oswaldo Cruz (2003) 0.82
"Putting a face" on HIV infection/AIDS in older adults: a psychosocial context. J Acquir Immune Defic Syndr (2003) 0.81
[Hantavirus in human and rodent population in an endemic area for hantavirus pulmonary syndrome in Argentina]. Medicina (B Aires) (2002) 0.79
Hantavirus pulmonary syndrome: encephalitis caused by virus Andes. J Neurovirol (2011) 0.78
HUMANS: An English and Spanish neuropsychological test battery for assessing HIV-1-infected individuals--initial report. Appl Neuropsychol (2004) 0.78
Digital Sympathectomy in Patients With Scleroderma: An Overview of the Practice and Referral Patterns and Perceptions of Rheumatologists. Ann Plast Surg (2015) 0.77
[Hantavirus pulmonary syndrome in Buenos Aires, 2009-2014]. Medicina (B Aires) (2016) 0.76
Equivalency of Spanish language versions of the trail making test part B including or excluding "CH". Clin Neuropsychol (2008) 0.75
Is carpal tunnel release under-utilized in veterans with spinal cord injury? J Spinal Cord Med (2011) 0.75
Hantavirus Pulmonary Syndrome in a COVID-19 Patient, Argentina, 2020. Emerg Infect Dis (2022) 0.75
Surgical versus nonsurgical treatment of femur fractures in people with spinal cord injury: an administrative analysis of risks. Arch Phys Med Rehabil (2013) 0.75